Med. praxi. 2012;9(11):428-430

Some advances in osteoporosis and bone metabolism

prof.MUDr.Vladimír Palička, CSc.
Osteocentrum, ÚKBD, Fakultní nemocnice a Lékařská fakulta UK, Hradec Králové

Although no longer a breakthrough issue, the field of osteoporosis surprises with a lot of new advances. There have been increasing

data on new treatment and new knowledge has emerged on the mechanism of action as well as on the side effects of well-established

treatment, and on whether and how osteoporosis treatment can affect fracture healing. In recent years, there has been a meteoric rise in

the number of publications on the link between bone metabolism and whole-body metabolism and the issue of vitamin D has remained

an evergreen and much-discussed "hit" in medicine.

Keywords: osteoporosis, treatment, vitamin D, fracture treatment

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Palička V. Some advances in osteoporosis and bone metabolism. Med. praxi. 2012;9(11):428-430.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abtahi J, Tengvall P, Aspenberg P. A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone 2012; 50: 1148-1151. Go to original source... Go to PubMed...
    2. Baron R, Hesse E. Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives. J. Clin. Endocrinol. Metab 2012; 97: 311-325. Go to original source... Go to PubMed...
    3. Bolland MJ, Grey A, Reid IR. Calcium Supplements and Cardiovascular Risk. J. Bone Miner. Res 2011; 26: 899. Go to original source... Go to PubMed...
    4. Cauley JA, Danielson ME, Boudreau R, Barbour KE, Horwitz MJ, Bauer DC, Ensrud KE, Manson JE, Wactawski-Wende J, Shikany JM, Jackson RD. Serum 25-Hydroxyvitamin D and Clinical Fracture Risk in a Multiethnic Cohort of Women: The Women's Health Initiative (WHI). J. Bone Miner. Res. 2011; 26: 2378-2388. Go to original source... Go to PubMed...
    5. Compston JE, Bilezikian JP. Bisphosphonate Therapy for Osteoporosis: The Long and Short of It. J. Bone Miner. Res 2012; 27: 240-242. Go to original source... Go to PubMed...
    6. Daugaard H, Elmengaard B, Andreassen T, Bechtold J, Lamberg A, Soballe K. Parathyroid hormone treatment increases fixation of orthopedic implants with gap healing: a biomechanical and histomorphometric canine study of porous coated titanium alloy implants in cancelous bone. Calcif. Tissue Int. 2011; 88: 294-303. Go to original source... Go to PubMed...
    7. Engelman CD. Vitamin D Recommendations: The Saga Continues. J. Clin. Endocrinol. Metab 2011; 96: 3065-3066. Go to original source... Go to PubMed...
    8. Fuchs RK, Faillace ME, Allen MR, Phipps RJ, Miller LM, Burr DB. Bisphosphonates do not alter the rate of secondary mineralization. Bone 2011; 49: 701-705. Go to original source... Go to PubMed...
    9. Gatti D, Viapiana O, Adami S. Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. Bone 2012; 50: 739-742. Go to original source... Go to PubMed...
    10. Hofstaetter JG, Hofstaetter SG, Nawrot-Wawrzyniak K, Hiertz H, Grohs JG, Trieb K, Windhager R, Klaushofer K, Roschger P. Mineralization pattern of vertebral bone material following fragility fracture of the spine. J. Orthop. Res. 2012; 30: 1089-1094. Go to original source... Go to PubMed...
    11. Kidd JL, Cowling NR, Wu AC, Kelly WL, Forwood MR. Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. J. Orthop. Res. 2011; 29: 1827-1833. Go to original source... Go to PubMed...
    12. Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH. Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort. J. Bone Miner. Res. 2011; 26: 993-1001. Go to original source... Go to PubMed...
    13. Lewis JR, Zhu K, Prince RL. Adverse Events From Calcium Supplementation: Relationship to Errors in Myocardial Infarction Self-Reporting in Randomized Controlled Trials of Calcium Supplementation. J. Bone Miner. Res 2012; 27: 719-722. Go to original source... Go to PubMed...
    14. Maravic M, Ostertag A, Cohen-Solal M. Subtrochanteric/ Femoral Shaft Versus Hip Fractures: Incidences and Identification of Risk Factors. J. Bone Miner. Res. 2012; 27: 130-137. Go to original source... Go to PubMed...
    15. Murad MH, Elamin KB, Elnour NOA, Elamin MB, Alkatib AA, Fatourechi MM, Almandoz JP, Mullan RJ, Lane MA, Liu H, Erwin PJ, Hensrud DD, Montori VM. The Effect of Vitamin D on Falls: A Systematic Review and Meta-Analysis. J. Clin. Endocrinol. Metab. 2011; 96: 2997-3006. Go to original source... Go to PubMed...
    16. Ominsky MS, Li Ch, Li X, Tan HL, Lee E, Barrero M, Asuncion FJ, Swyer D, Han Ch-Y, Vlasseros F, Samadfam R, Jolette J, Smith SY, Stolina M, Lacey DL, Simonet WS, Paszty Ch, Li G, Ke HZ. Inhibition of Sclerostin by Monoclonal Antibody Enhances Bone Healing and Improves Bone Density and Strength of Nonfractured Bones. J. Bone Miner. Res. 2011; 26: 1012-1021. Go to original source... Go to PubMed...
    17. Peichl P, Holzer LA, Maier L, Holzer G. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bone of elderly osteoporotic women. J. Bone Joint Surg. Am. 2011; 93: 1583-1587. Go to original source... Go to PubMed...
    18. Prisby R, Guignandon A, Vanden-Bossche A, Mac-Way F, Linossier M-T, Thomas M, Laroche N, Malaval L, Langer M, Peter Z-A, Peyrin F, Vico L, Lafage-Proust M-H. Intermittent PTH (1-84) Is Osteoanabolic but Not Osteoangiogenic and Relocates Bone Marrow Blood Vessels Closer to Bone-Forming Sites. J. Bone Miner. Res 2011; 26: 2583-2596. Go to original source... Go to PubMed...
    19. Reynolds DG, Takahata M, Lerner AL, O´Keefe RJ, Schwarz EM, Awad HA. Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model. Bone 2011; 48: 562-570. Go to original source... Go to PubMed...
    20. Sloan AV, Martin JR, Li S, Li J. Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair. Bone 2010; 47: 235-240. Go to original source... Go to PubMed...
    21. Takahata M, Schwarz EM, Chen T, O´Keefe RJ, Awad HA. Delayed Short-Course Treatment With Teriparatide (PTH1-34) Improves Femoral Allograft Healing by Enhancing Intramembranous Bone Formation at the Graft-Host Junction. J. Bone Miner. Res. 2012; 27: 26-37. Go to original source... Go to PubMed...
    22. Yavropoulou MP, Giusti A, Ramautar SR, Dijkstra S, Hamdy NAT, Papapoulos SE. Low-Energy Fractures of the Humeral Shaft and Bisphosphonate Use. J. Bone Miner. Res. 2012; 27: 1425-1431. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.